Roland Seifert - Publications

Affiliations: 
University of Kansas, Lawrence, KS, United States 
Area:
Pharmacology, Biochemistry, Molecular Biology

255 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Schneider EH, Hofmeister O, Kälble S, Seifert R. Apoptotic and anti-proliferative effect of guanosine and guanosine derivatives in HuT-78 T lymphoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 32313990 DOI: 10.1007/S00210-020-01864-8  0.319
2020 Gibhardt J, Heidemann JL, Bremenkamp R, Rosenberg J, Seifert R, Kaever V, Ficner R, Commichau FM. An extracytoplasmic protein and a moonlighting enzyme modulate synthesis of c-di-AMP in Listeria monocytogenes. Environmental Microbiology. PMID 32250026 DOI: 10.1111/1462-2920.15008  0.339
2019 Sayner SL, Choi CS, Maulucci ME, Kc R, Zhou C, Scruggs AK, Yarbrough T, Blair LAH, King JAC, Seifert R, Kaever V, Bauer NN. Extracellular vesicles: another compartment for the second messenger, cyclic adenosine monophosphate (cAMP). American Journal of Physiology. Lung Cellular and Molecular Physiology. PMID 30758991 DOI: 10.1152/Ajplung.00282.2018  0.325
2018 Scharrenbroich J, Kaever V, Dove S, Seifert R, Schneider EH. Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 30443663 DOI: 10.1007/S00210-018-1582-5  0.376
2017 Strasser A, Wittmann HJ, Seifert R. Binding Kinetics and Pathways of Ligands to GPCRs. Trends in Pharmacological Sciences. PMID 28645833 DOI: 10.1016/J.Tips.2017.05.005  0.329
2017 Dessauer CW, Watts VJ, Ostrom RS, Conti M, Dove S, Seifert R. International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. Pharmacological Reviews. 69: 93-139. PMID 28255005 DOI: 10.1124/Pr.116.013078  0.424
2017 Schneider EH, Seifert R. Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutantsin the Sf9 Cell Expression System. Handbook of Experimental Pharmacology. PMID 28233175 DOI: 10.1007/164_2016_124  0.442
2017 Schneider EH, Seifert R. Inactivation of Non-canonical Cyclic Nucleotides: Hydrolysis and Transport. Handbook of Experimental Pharmacology. PMID 28204955 DOI: 10.1007/164_2016_5004  0.339
2017 Seifert R. cCMP and cUMP Across the Tree of Life: From cCMP and cUMP Generators to cCMP- and cUMP-Regulated Cell Functions. Handbook of Experimental Pharmacology. PMID 28181008 DOI: 10.1007/164_2016_5005  0.312
2016 Berrisch S, Ostermeyer J, Kaever V, Kälble S, Hilfiker-Kleiner D, Seifert R, Schneider EH. cUMP hydrolysis by PDE3A. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 27975297 DOI: 10.1007/S00210-016-1328-1  0.356
2016 Dittmar F, Wolter S, Seifert R. Regulation of apoptosis by cyclic nucleotides in human erythroleukemia (HEL) cells and human myelogenous leukemia (K-562) cells. Biochemical Pharmacology. PMID 27157412 DOI: 10.1016/J.Bcp.2016.04.018  0.313
2016 Werner K, Neumann D, Seifert R. High constitutive Akt2 activity in U937 promonocytes: effective reduction of Akt2 phosphorylation by the histamine H2-receptor and the β2-adrenergic receptor. Naunyn-Schmiedeberg's Archives of Pharmacology. 389: 87-101. PMID 26475619 DOI: 10.1007/S00210-015-1179-1  0.368
2016 Karcz T, Handzlik J, Łażewska D, Kottke T, Seifert R, Kieć-Kononowicz K. Search for histamine H4 receptor ligands in the group of 4-methylpiperazino amide derivatives. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. S243-5. PMID 20058181 DOI: 10.1007/S00011-009-0141-4  0.352
2015 Beermann S, Bernhardt G, Seifert R, Buschauer A, Neumann D. Histamine H(1)- and H(4)-receptor signaling cooperatively regulate MAPK activation. Biochemical Pharmacology. 98: 432-9. PMID 26385311 DOI: 10.1016/J.Bcp.2015.09.011  0.337
2015 Littmann T, Göttle M, Reinartz MT, Kälble S, Wainer IW, Ozawa T, Seifert R. Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands. The Journal of Pharmacology and Experimental Therapeutics. 355: 183-90. PMID 26306764 DOI: 10.1124/Jpet.115.227959  0.337
2015 Wolter S, Kloth C, Golombek M, Dittmar F, Försterling L, Seifert R. cCMP causes caspase-dependent apoptosis in mouse lymphoma cell lines. Biochemical Pharmacology. 98: 119-31. PMID 26300059 DOI: 10.1016/J.Bcp.2015.08.096  0.336
2015 Lübker C, Dove S, Tang WJ, Urbauer RJ, Moskovitz J, Urbauer JL, Seifert R. Different Roles of N-Terminal and C-Terminal Domains in Calmodulin for Activation of Bacillus anthracis Edema Factor. Toxins. 7: 2598-614. PMID 26184312 DOI: 10.3390/Toxins7072598  0.322
2015 Werner K, Kälble S, Wolter S, Schneider EH, Buschauer A, Neumann D, Seifert R. Flow cytometric analysis with a fluorescently labeled formyl peptide receptor ligand as a new method to study the pharmacological profile of the histamine H2 receptor. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 1039-52. PMID 26021872 DOI: 10.1007/S00210-015-1133-2  0.364
2015 Lübker C, Seifert R. Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor. Plos One. 10: e0124017. PMID 25946093 DOI: 10.1371/Journal.Pone.0124017  0.378
2015 Heifetz A, Schertler GF, Seifert R, Tate CG, Sexton PM, Gurevich VV, Fourmy D, Cherezov V, Marshall FH, Storer RI, Moraes I, Tikhonova IG, Tautermann CS, Hunt P, Ceska T, et al. GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 883-903. PMID 25772061 DOI: 10.1007/S00210-015-1111-8  0.305
2015 Kagermeier N, Werner K, Keller M, Baumeister P, Bernhardt G, Seifert R, Buschauer A. Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists. Bioorganic & Medicinal Chemistry. 23: 3957-69. PMID 25639885 DOI: 10.1016/J.Bmc.2015.01.012  0.385
2015 Reinartz MT, Kälble S, Wainer IW, Seifert R. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 517-24. PMID 25637582 DOI: 10.1007/S00210-015-1086-5  0.392
2015 Michel MC, Seifert R. Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms. American Journal of Physiology. Cell Physiology. 308: C505-20. PMID 25631871 DOI: 10.1152/Ajpcell.00389.2014  0.358
2015 Seifert R, Schneider EH, Bähre H. From canonical to non-canonical cyclic nucleotides as second messengers: pharmacological implications. Pharmacology & Therapeutics. 148: 154-84. PMID 25527911 DOI: 10.1016/J.Pharmthera.2014.12.002  0.379
2015 Lübker C, Urbauer RJ, Moskovitz J, Dove S, Weisemann J, Fedorova M, Urbauer JL, Seifert R. Membranous adenylyl cyclase 1 activation is regulated by oxidation of N- and C-terminal methionine residues in calmodulin. Biochemical Pharmacology. 93: 196-209. PMID 25462816 DOI: 10.1016/J.Bcp.2014.11.007  0.332
2015 Seifert R. cCMP and cUMP: emerging second messengers. Trends in Biochemical Sciences. 40: 8-15. PMID 25435399 DOI: 10.1016/J.Tibs.2014.10.008  0.315
2015 Reinartz MT, Kälble S, Littmann T, Ozawa T, Dove S, Kaever V, Wainer IW, Seifert R. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 51-65. PMID 25342094 DOI: 10.1007/S00210-014-1054-5  0.36
2015 Wifling D, Löffel K, Nordemann U, Strasser A, Bernhardt G, Dove S, Seifert R, Buschauer A. Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants. British Journal of Pharmacology. 172: 785-798. PMID 24903527 DOI: 10.1111/Bph.12801  0.343
2015 Seifert R, Hartwig C, Wolter S, Schneider E, Bähre H, Kaever V. cIMP: Synthesis, effector activation, inactivation and occurrence in biological systems Bmc Pharmacology and Toxicology. 16. DOI: 10.1186/2050-6511-16-S1-A85  0.344
2015 Schneider E, Wolter S, Dittmar F, Fernández G, Seifert R. Differentiation between first and second messenger effects of cGMP Bmc Pharmacology and Toxicology. 16. DOI: 10.1186/2050-6511-16-S1-A84  0.335
2014 Werner K, Neumann D, Buschauer A, Seifert R. No evidence for histamine H4 receptor in human monocytes. The Journal of Pharmacology and Experimental Therapeutics. 351: 519-26. PMID 25273276 DOI: 10.1124/Jpet.114.218107  0.332
2014 Beermann S, Vauth M, Hein R, Seifert R, Neumann D. Distinct signalling pathways of murine histamine H1- and H4-receptors expressed at comparable levels in HEK293 cells. Plos One. 9: e107481. PMID 25243776 DOI: 10.1371/Journal.Pone.0107481  0.363
2014 Werner K, Neumann D, Seifert R. Analysis of the histamine H2-receptor in human monocytes. Biochemical Pharmacology. 92: 369-79. PMID 25199456 DOI: 10.1016/J.Bcp.2014.08.028  0.409
2014 Wolter S, Dove S, Golombek M, Schwede F, Seifert R. N4-monobutyryl-cCMP activates PKA RIα and PKA RIIα more potently and with higher efficacy than PKG Iα in vitro but not in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 387: 1163-75. PMID 25192685 DOI: 10.1007/S00210-014-1042-9  0.404
2014 Monzel M, Kuhn M, Bähre H, Seifert R, Schneider EH. PDE7A1 hydrolyzes cCMP. Febs Letters. 588: 3469-74. PMID 25128584 DOI: 10.1016/J.Febslet.2014.08.005  0.302
2014 Beckert U, Grundmann M, Wolter S, Schwede F, Rehmann H, Kaever V, Kostenis E, Seifert R. cNMP-AMs mimic and dissect bacterial nucleotidyl cyclase toxin effects. Biochemical and Biophysical Research Communications. 451: 497-502. PMID 25108158 DOI: 10.1016/J.Bbrc.2014.07.134  0.379
2014 Wittmann HJ, Seifert R, Strasser A. Sodium binding to hH3R and hH 4R--a molecular modeling study. Journal of Molecular Modeling. 20: 2394. PMID 25098339 DOI: 10.1007/S00894-014-2394-2  0.338
2014 Hartwig C, Bähre H, Wolter S, Beckert U, Kaever V, Seifert R. cAMP, cGMP, cCMP and cUMP concentrations across the tree of life: High cCMP and cUMP levels in astrocytes. Neuroscience Letters. 579: 183-7. PMID 25062586 DOI: 10.1016/J.Neulet.2014.07.019  0.324
2014 Beckert U, Wolter S, Hartwig C, Bähre H, Kaever V, Ladant D, Frank DW, Seifert R. ExoY from Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for cGMP and cUMP formation. Biochemical and Biophysical Research Communications. 450: 870-4. PMID 24971548 DOI: 10.1016/J.Bbrc.2014.06.088  0.345
2014 Seifert R. Therapeutic efficacy of a H₄ receptor antagonist in humans: a milestone in histamine research. The Journal of Pharmacology and Experimental Therapeutics. 350: 2-4. PMID 24925898 DOI: 10.1124/Jpet.114.215749Comm  0.315
2014 Hasan A, Danker KY, Wolter S, Bähre H, Kaever V, Seifert R. Soluble adenylyl cyclase accounts for high basal cCMP and cUMP concentrations in HEK293 and B103 cells. Biochemical and Biophysical Research Communications. 448: 236-40. PMID 24792377 DOI: 10.1016/J.Bbrc.2014.04.099  0.386
2014 Dove S, Danker KY, Stasch JP, Kaever V, Seifert R. Structure/activity relationships of (M)ANT- and TNP-nucleotides for inhibition of rat soluble guanylyl cyclase α1β1. Molecular Pharmacology. 85: 598-607. PMID 24470063 DOI: 10.1124/Mol.113.091017  0.417
2014 Bähre H, Danker KY, Stasch JP, Kaever V, Seifert R. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells. Biochemical and Biophysical Research Communications. 443: 1195-9. PMID 24380860 DOI: 10.1016/J.Bbrc.2013.12.108  0.356
2014 Bräunig JH, Albrecht-Küpper B, Seifert R. Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 387: 389-98. PMID 24276219 DOI: 10.1007/S00210-013-0943-3  0.358
2014 Neumann D, Schneider EH, Seifert R. Analysis of histamine receptor knockout mice in models of inflammation. The Journal of Pharmacology and Experimental Therapeutics. 348: 2-11. PMID 24101735 DOI: 10.1124/Jpet.113.204214  0.319
2014 Reinartz MT, Seifert R. Funktionelle Selektivität am Beispiel des β2-Adrenozeptors Biospektrum. 20: 130-135. DOI: 10.1007/S12268-014-0415-4  0.346
2013 Seifert R. Correspondence (letter to the editor): Numerous errors. Deutsches äRzteblatt International. 110: 557. PMID 24069080 DOI: 10.3238/Arztebl.2013.0557A  0.372
2013 Nordemann U, Wifling D, Schnell D, Bernhardt G, Stark H, Seifert R, Buschauer A. Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: correlations and discrepancies between distal and proximal readouts. Plos One. 8: e73961. PMID 24023919 DOI: 10.1371/Journal.Pone.0073961  0.395
2013 Beckert U, Aw WY, Burhenne H, Försterling L, Kaever V, Timmons L, Seifert R. The Receptor-Bound Guanylyl Cyclase DAF-11 Is the Mediator of Hydrogen Peroxide-Induced cGMP Increase in Caenorhabditis elegans [corrected].. Plos One. 8: e72569. PMID 24015261 DOI: 10.1371/Journal.Pone.0072569  0.362
2013 Seifert R. Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells. Biochemical Pharmacology. 86: 853-61. PMID 23933388 DOI: 10.1016/J.Bcp.2013.07.029  0.372
2013 Beste KY, Spangler CM, Burhenne H, Koch KW, Shen Y, Tang WJ, Kaever V, Seifert R. Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor. Plos One. 8: e70223. PMID 23922959 DOI: 10.1371/Journal.Pone.0070223  0.359
2013 Seifert R, Dove S. Inhibitors of Bacillus anthracis edema factor. Pharmacology & Therapeutics. 140: 200-12. PMID 23850654 DOI: 10.1016/J.Pharmthera.2013.07.002  0.39
2013 Braeunig JH, Schweda F, Han PL, Seifert R. Similarly potent inhibition of adenylyl cyclase by P-site inhibitors in hearts from wild type and AC5 knockout mice. Plos One. 8: e68009. PMID 23840883 DOI: 10.1371/Journal.Pone.0068009  0.351
2013 Brunskole Hummel I, Reinartz MT, Kälble S, Burhenne H, Schwede F, Buschauer A, Seifert R. Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity. Plos One. 8: e64556. PMID 23741338 DOI: 10.1371/Journal.Pone.0064556  0.382
2013 Seifert R. Regulation of G protein subunit composition in cardiomyocytes: pharmacological implications. Naunyn-Schmiedeberg's Archives of Pharmacology. 386: 455-7. PMID 23568551 DOI: 10.1007/S00210-013-0864-1  0.317
2013 Reinecke D, Schwede F, Genieser HG, Seifert R. Analysis of substrate specificity and kinetics of cyclic nucleotide phosphodiesterases with N'-methylanthraniloyl-substituted purine and pyrimidine 3',5'-cyclic nucleotides by fluorescence spectrometry. Plos One. 8: e54158. PMID 23342095 DOI: 10.1371/Journal.Pone.0054158  0.379
2013 Seifert R, Strasser A, Schneider EH, Neumann D, Dove S, Buschauer A. Molecular and cellular analysis of human histamine receptor subtypes. Trends in Pharmacological Sciences. 34: 33-58. PMID 23254267 DOI: 10.1016/J.Tips.2012.11.001  0.318
2013 Strasser A, Wittmann HJ, Buschauer A, Schneider EH, Seifert R. Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs. Trends in Pharmacological Sciences. 34: 13-32. PMID 23228711 DOI: 10.1016/J.Tips.2012.10.004  0.364
2013 Beste KY, Seifert R. cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: development of a hypothesis based on studies with soluble guanylyl cyclase α(1)β(1). Biological Chemistry. 394: 261-70. PMID 23087103 DOI: 10.1515/Hsz-2012-0282  0.337
2013 Wolter S, Golombek M, Schwede F, Genieser H, Dove S, Seifert R. Activation profile of cGMP-dependent protein kinase Iα Bmc Pharmacology and Toxicology. 14. DOI: 10.1186/2050-6511-14-S1-P79  0.404
2013 Schneider E, Kuhn M, Reinecke D, Wolter S, Burhenne H, Kaever V, Seifert R. Fishing for elusive cCMP-degrading phosphodiesterases Bmc Pharmacology and Toxicology. 14. DOI: 10.1186/2050-6511-14-S1-P62  0.323
2013 Seifert R, Hartwig C, Wolter S, Reinecke D, Burhenne H, Kaever V, Munder A, Tümmler B, Schwede F, Grundmann M, Kostenis E, Frank DW, Beckert U. Pseudomonas aeruginosaExoY, a cyclic GMP- and cyclic UMP-generating nucleotidyl cyclase Bmc Pharmacology and Toxicology. 14. DOI: 10.1186/2050-6511-14-S1-O36  0.363
2012 Seifert R, Beste KY. Allosteric regulation of nucleotidyl cyclases: an emerging pharmacological target. Science Signaling. 5: pe37. PMID 22949734 DOI: 10.1126/Scisignal.2003466  0.327
2012 Reher TM, Brunskole I, Neumann D, Seifert R. Evidence for ligand-specific conformations of the histamine H(2)-receptor in human eosinophils and neutrophils. Biochemical Pharmacology. 84: 1174-85. PMID 22922404 DOI: 10.1016/J.Bcp.2012.08.014  0.341
2012 Göttle M, Dove S, Seifert R. Bacillus anthracis edema factor substrate specificity: evidence for new modes of action. Toxins. 4: 505-35. PMID 22852066 DOI: 10.3390/Toxins4070505  0.36
2012 Hammerschmidt A, Chatterji B, Zeiser J, Schröder A, Genieser HG, Pich A, Kaever V, Schwede F, Wolter S, Seifert R. Binding of regulatory subunits of cyclic AMP-dependent protein kinase to cyclic CMP agarose. Plos One. 7: e39848. PMID 22808067 DOI: 10.1371/Journal.Pone.0039848  0.363
2012 Gorinski N, Kowalsman N, Renner U, Wirth A, Reinartz MT, Seifert R, Zeug A, Ponimaskin E, Niv MY. Computational and experimental analysis of the transmembrane domain 4/5 dimerization interface of the serotonin 5-HT(1A) receptor. Molecular Pharmacology. 82: 448-63. PMID 22669805 DOI: 10.1124/Mol.112.079137  0.309
2012 Seifert R, Dove S. Towards selective inhibitors of adenylyl cyclase toxin from Bordetella pertussis. Trends in Microbiology. 20: 343-51. PMID 22578665 DOI: 10.1016/J.Tim.2012.04.002  0.369
2012 Kinast L, von der Ohe J, Burhenne H, Seifert R. Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool. Naunyn-Schmiedeberg's Archives of Pharmacology. 385: 671-83. PMID 22552731 DOI: 10.1007/S00210-012-0759-6  0.373
2012 Reher TM, Neumann D, Buschauer A, Seifert R. Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations. Biochemical Pharmacology. 84: 192-203. PMID 22516788 DOI: 10.1016/J.Bcp.2012.04.004  0.341
2012 Schuler D, Lübker C, Lushington GH, Tang WJ, Shen Y, Richter M, Seifert R. Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I. Biochemical Pharmacology. 83: 839-48. PMID 22265637 DOI: 10.1016/J.Bcp.2012.01.005  0.386
2012 Birnkammer T, Spickenreither A, Brunskole I, Lopuch M, Kagermeier N, Bernhardt G, Dove S, Seifert R, Elz S, Buschauer A. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists. Journal of Medicinal Chemistry. 55: 1147-60. PMID 22216892 DOI: 10.1021/Jm201128Q  0.336
2012 Beste KY, Burhenne H, Kaever V, Stasch JP, Seifert R. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1. Biochemistry. 51: 194-204. PMID 22122229 DOI: 10.1021/Bi201259Y  0.421
2012 Seifert R, Lushington GH, Mou TC, Gille A, Sprang SR. Inhibitors of membranous adenylyl cyclases. Trends in Pharmacological Sciences. 33: 64-78. PMID 22100304 DOI: 10.1016/J.Tips.2011.10.006  0.707
2012 Beermann S, Seifert R, Neumann D. Commercially available antibodies against human and murine histamine H₄-receptor lack specificity. Naunyn-Schmiedeberg's Archives of Pharmacology. 385: 125-35. PMID 22071576 DOI: 10.1007/S00210-011-0700-4  0.311
2012 Appl H, Holzammer T, Dove S, Haen E, Strasser A, Seifert R. Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics. Naunyn-Schmiedeberg's Archives of Pharmacology. 385: 145-70. PMID 22033803 DOI: 10.1007/S00210-011-0704-0  0.365
2012 Taha H, Dove S, Geduhn J, König B, Shen Y, Tang WJ, Seifert R. Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5'-triphosphates. Naunyn-Schmiedeberg's Archives of Pharmacology. 385: 57-68. PMID 21947230 DOI: 10.1007/S00210-011-0688-9  0.405
2012 Beste KY, Burhenne H, Kaever V, Stasch J, Seifert R. Correction to Nucleotidyl Cyclase Activity of Soluble Guanylyl Cyclase α1β1 Biochemistry. 51: 2357-2357. DOI: 10.1021/Bi3002715  0.329
2011 Wolter S, Golombek M, Seifert R. Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides. Biochemical and Biophysical Research Communications. 415: 563-6. PMID 22074826 DOI: 10.1016/J.Bbrc.2011.10.093  0.369
2011 Erdorf M, von der Ohe J, Seifert R. Impaired P2X and P2Y receptor-mediated signaling in HPRT-deficient B103 neuroblastoma cells. Neuroscience Letters. 504: 311-5. PMID 21982803 DOI: 10.1016/J.Neulet.2011.09.054  0.347
2011 Wittmann HJ, Seifert R, Strasser A. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R. Biochemical Pharmacology. 82: 1910-8. PMID 21933664 DOI: 10.1016/J.Bcp.2011.09.005  0.325
2011 Reinecke D, Burhenne H, Sandner P, Kaever V, Seifert R. Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated. Febs Letters. 585: 3259-62. PMID 21920362 DOI: 10.1016/J.Febslet.2011.09.004  0.342
2011 Erdorf M, Mou TC, Seifert R. Impact of divalent metal ions on regulation of adenylyl cyclase isoforms by forskolin analogs. Biochemical Pharmacology. 82: 1673-81. PMID 21843517 DOI: 10.1016/J.Bcp.2011.07.099  0.369
2011 Wittmann HJ, Elz S, Seifert R, Straber A. N (α)-Methylated phenylhistamines exhibit affinity to the hH(4)R-a pharmacological and molecular modelling study. Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 287-99. PMID 21800095 DOI: 10.1007/S00210-011-0671-5  0.302
2011 Brunskole I, Strasser A, Seifert R, Buschauer A. Role of the second and third extracellular loops of the histamine H(4) receptor in receptor activation. Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 301-17. PMID 21800093 DOI: 10.1007/S00210-011-0673-3  0.307
2011 Pop N, Igel P, Brennauer A, Cabrele C, Bernhardt GN, Seifert R, Buschauer A. Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells. Journal of Receptor and Signal Transduction Research. 31: 271-85. PMID 21745157 DOI: 10.3109/10799893.2011.583253  0.342
2011 Sutor S, Heilmann J, Seifert R. Impact of fusion to Gα i2 and co-expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB 1R and CB 2R Journal of Pharmacy and Pharmacology. 63: 1043-1055. PMID 21718288 DOI: 10.1111/J.2042-7158.2011.01307.X  0.365
2011 Rossbach K, Nassenstein C, Gschwandtner M, Schnell D, Sander K, Seifert R, Stark H, Kietzmann M, Bäumer W. Histamine H1, H3 and H4 receptors are involved in pruritus. Neuroscience. 190: 89-102. PMID 21689731 DOI: 10.1016/J.Neuroscience.2011.06.002  0.3
2011 Pinto C, Lushington GH, Richter M, Gille A, Geduhn J, König B, Mou TC, Sprang SR, Seifert R. Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases. Biochemical Pharmacology. 82: 358-70. PMID 21620805 DOI: 10.1016/J.Bcp.2011.05.010  0.796
2011 Hübner M, Dixit A, Mou TC, Lushington GH, Pinto C, Gille A, Geduhn J, König B, Sprang SR, Seifert R. Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate. Molecular Pharmacology. 80: 87-96. PMID 21498658 DOI: 10.1124/Mol.111.071894  0.789
2011 Więcek M, Kottke T, Ligneau X, Schunack W, Seifert R, Stark H, Handzlik J, Kieć-Kononowicz K. N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands. Bioorganic & Medicinal Chemistry. 19: 2850-8. PMID 21498080 DOI: 10.1016/J.Bmc.2011.03.046  0.351
2011 Hübner M, Dizayee S, Matthes J, Seifert R, Herzig S. Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes. Naunyn-Schmiedeberg's Archives of Pharmacology. 383: 573-83. PMID 21484439 DOI: 10.1007/S00210-011-0626-X  0.352
2011 Schnell D, Brunskole I, Ladova K, Schneider EH, Igel P, Dove S, Buschauer A, Seifert R. Expression and functional properties of canine, rat, and murine histamine H₄ receptors in Sf9 insect cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 383: 457-70. PMID 21359967 DOI: 10.1007/S00210-011-0612-3  0.343
2011 Erdorf M, Seifert R. Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 383: 357-72. PMID 21279330 DOI: 10.1007/S00210-011-0600-7  0.364
2011 Seifert R, Schneider EH, Dove S, Brunskole I, Neumann D, Strasser A, Buschauer A. Paradoxical stimulatory effects of the "standard" histamine H4-receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity. Molecular Pharmacology. 79: 631-8. PMID 21266488 DOI: 10.1124/Mol.111.071266  0.387
2011 Kottke T, Sander K, Weizel L, Schneider EH, Seifert R, Stark H. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands. European Journal of Pharmacology. 654: 200-8. PMID 21237145 DOI: 10.1016/J.Ejphar.2010.12.033  0.338
2011 Geduhn J, Dove S, Shen Y, Tang WJ, König B, Seifert R. Bis-halogen-anthraniloyl-substituted nucleoside 5'-triphosphates as potent and selective inhibitors of Bordetella pertussis adenylyl cyclase toxin. The Journal of Pharmacology and Experimental Therapeutics. 336: 104-15. PMID 20962032 DOI: 10.1124/Jpet.110.174219  0.409
2011 Wolter S, Golombek M, Hammerschmidt A, Schwede F, Genieser H, Seifert R. Activation of cGMP-dependent protein kinase Iα and cAMP-dependent protein kinase A isoforms by cyclic nucleotides Bmc Pharmacology. 11. DOI: 10.1186/1471-2210-11-S1-P76  0.388
2011 Voigt U, Burhenne H, Sonnow L, Wölfel C, Spangler C, Ladant D, Frank DW, Kaever V, Seifert R. The effector protein ExoY secreted by Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for GTP Bmc Pharmacology. 11. DOI: 10.1186/1471-2210-11-S1-P74  0.344
2011 Beste KY, Stasch J, Kaever V, Seifert R. Evidence for two catalytic centers and Mn2+ as physiological cofactor of soluble guanylyl cyclase Bmc Pharmacology. 11. DOI: 10.1186/1471-2210-11-S1-P7  0.381
2011 Seifert R, Beste K, Burhenne H, Voigt U, Wolter S, Hammerschmidt A, Reinecke D, Sandner P, Pich A, Schwede F, Genieser HG, Kaever V. Cyclic CMP and cyclic UMP: new (old) second messengers Bmc Pharmacology. 11. DOI: 10.1186/1471-2210-11-S1-O34  0.345
2010 Schneider EH, Seifert R. Coexpression systems as models for the analysis of constitutive GPCR activity. Methods in Enzymology. 485: 527-57. PMID 21050935 DOI: 10.1016/B978-0-12-381296-4.00028-2  0.317
2010 Schneider EH, Seifert R. Fusion proteins as model systems for the analysis of constitutive GPCR activity. Methods in Enzymology. 485: 459-80. PMID 21050932 DOI: 10.1016/B978-0-12-381296-4.00025-7  0.368
2010 Spangler C, Kaever V, Seifert R. Interaction of the diguanylate cyclase YdeH of Escherichia coli with 2',(3')-substituted purine and pyrimidine nucleotides. The Journal of Pharmacology and Experimental Therapeutics. 336: 234-41. PMID 20947637 DOI: 10.1124/Jpet.110.170993  0.401
2010 Schneider EH, Seifert R. Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors. Pharmacology & Therapeutics. 128: 387-418. PMID 20705094 DOI: 10.1016/J.Pharmthera.2010.07.005  0.4
2010 Desch M, Schinner E, Kees F, Hofmann F, Seifert R, Schlossmann J. Cyclic cytidine 3',5'-monophosphate (cCMP) signals via cGMP kinase I. Febs Letters. 584: 3979-84. PMID 20691687 DOI: 10.1016/J.Febslet.2010.07.059  0.348
2010 Schnell D, Strasser A, Seifert R. Comparison of the pharmacological properties of human and rat histamine H(3)-receptors. Biochemical Pharmacology. 80: 1437-49. PMID 20688049 DOI: 10.1016/J.Bcp.2010.07.027  0.334
2010 Geiger S, Nickl K, Schneider EH, Seifert R, Heilmann J. Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands. Naunyn-Schmiedeberg's Archives of Pharmacology. 382: 177-91. PMID 20617431 DOI: 10.1007/S00210-010-0534-5  0.379
2010 Göttle M, Dove S, Kees F, Schlossmann J, Geduhn J, König B, Shen Y, Tang WJ, Kaever V, Seifert R. Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry. 49: 5494-503. PMID 20521845 DOI: 10.1021/Bi100684G  0.38
2010 Schneider EH, Strasser A, Thurmond RL, Seifert R. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 334: 513-21. PMID 20484153 DOI: 10.1124/Jpet.110.165977  0.345
2010 Sander K, Kottke T, Hoffend C, Walter M, Weizel L, Camelin JC, Ligneau X, Schneider EH, Seifert R, Schwartz JC, Stark H. First metal-containing histamine H3 receptor ligands. Organic Letters. 12: 2578-81. PMID 20446742 DOI: 10.1021/Ol100419Y  0.321
2010 Ghorai P, Kraus A, Birnkammer T, Geyer R, Bernhardt G, Dove S, Seifert R, Elz S, Buschauer A. Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity. Bioorganic & Medicinal Chemistry Letters. 20: 3173-6. PMID 20409707 DOI: 10.1016/J.Bmcl.2010.03.082  0.324
2010 Schnell D, Seifert R. Modulation of histamine H(3) receptor function by monovalent ions. Neuroscience Letters. 472: 114-8. PMID 20132865 DOI: 10.1016/J.Neulet.2010.01.065  0.413
2010 Schneider EH, Schnell D, Strasser A, Dove S, Seifert R. Impact of the DRY motif and the missing "ionic lock" on constitutive activity and G-protein coupling of the human histamine H4 receptor. The Journal of Pharmacology and Experimental Therapeutics. 333: 382-92. PMID 20106995 DOI: 10.1124/Jpet.109.163220  0.333
2010 Kuder KJ, Kottke T, Stark H, Ligneau X, Camelin JC, Seifert R, Kieć-Kononowicz K. Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. S247-8. PMID 20091085 DOI: 10.1007/S00011-009-0142-3  0.309
2010 Emmrich T, El-Tayeb A, Taha H, Seifert R, Müller CE, Link A. Synthesis of a hydrolytically stable, fluorescent-labeled ATP analog as a tool for probing adenylyl cyclases. Bioorganic & Medicinal Chemistry Letters. 20: 232-5. PMID 19914832 DOI: 10.1016/J.Bmcl.2009.10.125  0.341
2009 Schnell D, Burleigh K, Trick J, Seifert R. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers. The Journal of Pharmacology and Experimental Therapeutics. 332: 996-1005. PMID 19959746 DOI: 10.1124/Jpet.109.162339  0.389
2009 Łazewska D, Wiecek M, Ligneau X, Kottke T, Weizel L, Seifert R, Schunack W, Stark H, Kieć-Kononowicz K. Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Bioorganic & Medicinal Chemistry Letters. 19: 6682-5. PMID 19846299 DOI: 10.1016/J.Bmcl.2009.10.005  0.31
2009 Igel P, Geyer R, Strasser A, Dove S, Seifert R, Buschauer A. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists. Journal of Medicinal Chemistry. 52: 6297-313. PMID 19791743 DOI: 10.1021/Jm900526H  0.386
2009 Suryanarayana S, Pinto C, Mou TC, Richter M, Lushington GH, Seifert R. The C1 homodimer of adenylyl cyclase binds nucleotides with high affinity but possesses exceedingly low catalytic activity. Neuroscience Letters. 467: 1-5. PMID 19788911 DOI: 10.1016/J.Neulet.2009.09.049  0.794
2009 Sander K, Kottke T, Tanrikulu Y, Proschak E, Weizel L, Schneider EH, Seifert R, Schneider G, Stark H. 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization. Bioorganic & Medicinal Chemistry. 17: 7186-96. PMID 19773175 DOI: 10.1016/J.Bmc.2009.08.059  0.345
2009 Deml KF, Beermann S, Neumann D, Strasser A, Seifert R. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor. Molecular Pharmacology. 76: 1019-30. PMID 19720730 DOI: 10.1124/Mol.109.058651  0.366
2009 Suryanarayana S, Göttle M, Hübner M, Gille A, Mou TC, Sprang SR, Richter M, Seifert R. Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates. The Journal of Pharmacology and Experimental Therapeutics. 330: 687-95. PMID 19494187 DOI: 10.1124/Jpet.109.155432  0.721
2009 Suryanarayana S, Wang JL, Richter M, Shen Y, Tang WJ, Lushington GH, Seifert R. Distinct interactions of 2'- and 3'-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor. Biochemical Pharmacology. 78: 224-30. PMID 19492438 DOI: 10.1016/J.Bcp.2009.04.006  0.399
2009 Schneider EH, Seifert R. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands. Biochemical Pharmacology. 78: 607-16. PMID 19464266 DOI: 10.1016/J.Bcp.2009.05.015  0.358
2009 Pinto C, Hübner M, Gille A, Richter M, Mou TC, Sprang SR, Seifert R. Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs. Biochemical Pharmacology. 78: 62-9. PMID 19447224 DOI: 10.1016/J.Bcp.2009.03.023  0.777
2009 Wittmann HJ, Seifert R, Strasser A. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor. Molecular Pharmacology. 76: 25-37. PMID 19346300 DOI: 10.1124/Mol.109.055384  0.319
2009 Tanrikulu Y, Proschak E, Werner T, Geppert T, Todoroff N, Klenner A, Kottke T, Sander K, Schneider E, Seifert R, Stark H, Clark T, Schneider G. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor. Chemmedchem. 4: 820-7. PMID 19343764 DOI: 10.1002/Cmdc.200800443  0.328
2009 Igel P, Schneider E, Schnell D, Elz S, Seifert R, Buschauer A. N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent. Journal of Medicinal Chemistry. 52: 2623-7. PMID 19317445 DOI: 10.1021/Jm9000693  0.329
2009 Göttle M, Geduhn J, König B, Gille A, Höcherl K, Seifert R. Characterization of mouse heart adenylyl cyclase. The Journal of Pharmacology and Experimental Therapeutics. 329: 1156-65. PMID 19307450 DOI: 10.1124/Jpet.109.150953  0.677
2009 Schneider EH, Schnell D, Papa D, Seifert R. High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor. Biochemistry. 48: 1424-38. PMID 19166345 DOI: 10.1021/Bi802050D  0.405
2009 Igel P, Schnell D, Bernhardt G, Seifert R, Buschauer A. Tritium-labeled N(1)-[3-(1H-imidazol-4-yl)propyl]-N(2)-propionylguanidine ([(3)H]UR-PI294), a high-affinity histamine H(3) and H(4) receptor radioligand. Chemmedchem. 4: 225-31. PMID 19101971 DOI: 10.1002/Cmdc.200800349  0.312
2009 Kraus A, Ghorai P, Birnkammer T, Schnell D, Elz S, Seifert R, Dove S, Bernhardt G, Buschauer A. N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists. Chemmedchem. 4: 232-40. PMID 19072936 DOI: 10.1002/Cmdc.200800296  0.367
2009 Taha HM, Schmidt J, Göttle M, Suryanarayana S, Shen Y, Tang WJ, Gille A, Geduhn J, König B, Dove S, Seifert R. Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides. Molecular Pharmacology. 75: 693-703. PMID 19056899 DOI: 10.1124/Mol.108.052340  0.72
2009 Strasser A, Wittmann HJ, Kunze M, Elz S, Seifert R. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor. Molecular Pharmacology. 75: 454-65. PMID 19047480 DOI: 10.1124/Mol.108.053009  0.343
2009 Spangler CM, Wilhelm B, Burhenne H, Rauch K, Seifert R, Kaever V. Sensitive assay for the detection of cyclic nucleotides by mass spectrometry Bmc Pharmacology. 9. DOI: 10.1186/1471-2210-9-S1-P66  0.313
2009 Göttle M, Kees F, Seifert R. Cytidylyl cyclase activity of bacterial exotoxins Bmc Pharmacology. 9: P16. DOI: 10.1186/1471-2210-9-S1-P16  0.369
2009 Egger M, Maity P, Hübner M, Seifert R, König B. Synthesis and Pharmacological Properties of New Tetracyclic Forskolin Analogues European Journal of Organic Chemistry. 2009: 3613-3618. DOI: 10.1002/Ejoc.200900260  0.33
2008 Seifert R, Dove S. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities. Molecular Pharmacology. 75: 13-8. PMID 19001067 DOI: 10.1124/Mol.108.052944  0.356
2008 Egger M, Pellett P, Nickl K, Geiger S, Graetz S, Seifert R, Heilmann J, König B. Synthesis and cannabinoid receptor activity of ketoalkenes from Echinacea pallida and nonnatural analogues. Chemistry (Weinheim An Der Bergstrasse, Germany). 14: 10978-84. PMID 18979494 DOI: 10.1002/Chem.200801579  0.314
2008 Ghorai P, Kraus A, Keller M, Götte C, Igel P, Schneider E, Schnell D, Bernhardt G, Dove S, Zabel M, Elz S, Seifert R, Buschauer A. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists. Journal of Medicinal Chemistry. 51: 7193-204. PMID 18950149 DOI: 10.1021/Jm800841W  0.35
2008 Nickl K, Gardner EE, Geiger S, Heilmann J, Seifert R. Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2. Neuroscience Letters. 447: 68-72. PMID 18845226 DOI: 10.1016/J.Neulet.2008.09.078  0.316
2008 Weitl N, Seifert R. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine. The Journal of Pharmacology and Experimental Therapeutics. 327: 760-9. PMID 18772317 DOI: 10.1124/Jpet.108.143412  0.334
2008 Spangler CM, Spangler C, Göttle M, Shen Y, Tang WJ, Seifert R, Schäferling M. A fluorimetric assay for real-time monitoring of adenylyl cyclase activity based on terbium norfloxacin. Analytical Biochemistry. 381: 86-93. PMID 18601890 DOI: 10.1016/J.Ab.2008.06.014  0.342
2008 Strasser A, Wittmann HJ, Seifert R. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor. The Journal of Pharmacology and Experimental Therapeutics. 326: 783-91. PMID 18577700 DOI: 10.1124/Jpet.108.140913  0.31
2008 Kleemann P, Papa D, Vigil-Cruz S, Seifert R. Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G (o)-proteins in Sf9 insect cells. Naunyn-Schmiedebergs Archives of Pharmacology. 378: 261-274. PMID 18523757 DOI: 10.1007/S00210-008-0313-8  0.417
2008 Pinto C, Papa D, Hübner M, Mou TC, Lushington GH, Seifert R. Activation and inhibition of adenylyl cyclase isoforms by forskolin analogs. The Journal of Pharmacology and Experimental Therapeutics. 325: 27-36. PMID 18184830 DOI: 10.1124/Jpet.107.131904  0.806
2007 Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R. Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists. Naunyn-Schmiedeberg's Archives of Pharmacology. 376: 253-64. PMID 17999052 DOI: 10.1007/S00210-007-0204-4  0.376
2007 Schlegel B, Laggner C, Meier R, Langer T, Schnell D, Seifert R, Stark H, Höltje HD, Sippl W. Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening Journal of Computer-Aided Molecular Design. 21: 437-453. PMID 17668276 DOI: 10.1007/S10822-007-9127-X  0.352
2007 Göttle M, Dove S, Steindel P, Shen Y, Tang WJ, Geduhn J, König B, Seifert R. Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides Molecular Pharmacology. 72: 526-535. PMID 17553924 DOI: 10.1124/Mol.107.034413  0.388
2007 Lorenz V, Pinto CS, Seifert R. Complex changes in ecto-nucleoside 5'-triphosphate diphosphohydrolase expression in hypoxanthine phosphoribosyl transferase deficiency. Neuroscience Letters. 420: 6-11. PMID 17459584 DOI: 10.1016/J.Neulet.2007.04.004  0.773
2007 Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity. The Journal of Pharmacology and Experimental Therapeutics. 321: 975-82. PMID 17347323 DOI: 10.1124/Jpet.107.120519  0.409
2007 Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors. The Journal of Pharmacology and Experimental Therapeutics. 321: 983-95. PMID 17332265 DOI: 10.1124/Jpet.107.120014  0.321
2007 Wang JL, Guo JX, Zhang QY, Wu JJ, Seifert R, Lushington GH. A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors. Bioorganic & Medicinal Chemistry. 15: 2993-3002. PMID 17329110 DOI: 10.1016/J.Bmc.2007.02.014  0.364
2007 Rottlaender D, Matthes J, Vatner SF, Seifert R, Herzig S. Functional adenylyl cyclase inhibition in murine cardiomyocytes by 2'(3')-O-(N-methylanthraniloyl)-guanosine 5'-[gamma-thio]triphosphate. The Journal of Pharmacology and Experimental Therapeutics. 321: 608-15. PMID 17284671 DOI: 10.1124/Jpet.106.118422  0.353
2007 Xie SX, Schalkhausser F, Ye QZ, Seifert R, Buschauer A. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors. Archiv Der Pharmazie. 340: 9-16. PMID 17206612 DOI: 10.1002/Ardp.200600140  0.387
2006 Pertz HH, Görnemann T, Schurad B, Seifert R, Strasser A. Striking differences of action of lisuride stereoisomers at histamine H1 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 374: 215-22. PMID 17106670 DOI: 10.1007/S00210-006-0111-0  0.331
2006 Mou TC, Gille A, Suryanarayana S, Richter M, Seifert R, Sprang SR. Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine- and pyrimidine nucleotide inhibitors. Molecular Pharmacology. 70: 878-86. PMID 16766715 DOI: 10.1124/Mol.106.026427  0.72
2006 Xie SX, Petrache G, Schneider E, Ye QZ, Bernhardt G, Seifert R, Buschauer A. Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine. Bioorganic & Medicinal Chemistry Letters. 16: 3886-90. PMID 16730977 DOI: 10.1016/J.Bmcl.2006.05.039  0.354
2006 Xie SX, Kraus A, Ghorai P, Ye QZ, Elz S, Buschauer A, Seifert R. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors. The Journal of Pharmacology and Experimental Therapeutics. 317: 1262-8. PMID 16554355 DOI: 10.1124/Jpet.106.102897  0.378
2006 Pinto CS, Seifert R. Decreased GTP-stimulated adenylyl cyclase activity in HPRT-deficient human and mouse fibroblast and rat B103 neuroblastoma cell membranes. Journal of Neurochemistry. 96: 454-9. PMID 16336632 DOI: 10.1111/J.1471-4159.2005.03570.X  0.792
2005 Kelly JJ, Stevens T, Thompson WJ, Seifert R. Adenylyl and guanylyl cyclase assays. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit2.2. PMID 21953389 DOI: 10.1002/0471141755.Ph0202S30  0.382
2005 Gille A, Guo J, Mou TC, Doughty MB, Lushington GH, Seifert R. Differential interactions of G-proteins and adenylyl cyclase with nucleoside 5'-triphosphates, nucleoside 5'-[gamma-thio]triphosphates and nucleoside 5'-[beta,gamma-imido]triphosphates. Biochemical Pharmacology. 71: 89-97. PMID 16271707 DOI: 10.1016/J.Bcp.2005.10.006  0.719
2005 Pinto CS, Jinnah HA, Shirley TL, Nyhan WL, Seifert R. Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines. Journal of Neurochemistry. 93: 1579-86. PMID 15935074 DOI: 10.1111/J.1471-4159.2005.03151.X  0.788
2005 Mou TC, Gille A, Fancy DA, Seifert R, Sprang SR. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate. The Journal of Biological Chemistry. 280: 7253-61. PMID 15591060 DOI: 10.1074/Jbc.M409076200  0.706
2005 Dove S, Elz S, Seifert R, Buschauer A. Structure-activity relationships of histamine H2 receptor ligands. Mini Reviews in Medicinal Chemistry. 4: 941-54. PMID 15544555 DOI: 10.2174/1389557043403242  0.358
2004 Gille A, Lushington GH, Mou TC, Doughty MB, Johnson RA, Seifert R. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides. The Journal of Biological Chemistry. 279: 19955-69. PMID 14981084 DOI: 10.1074/Jbc.M312560200  0.733
2004 Gille A, Seifert R. Xanthine nucleotide-specific G-protein alpha-subunits: a novel approach for the analysis of G-protein-mediated signal transduction. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 141-50. PMID 14654999 DOI: 10.1007/S00210-003-0844-Y  0.707
2003 Menghin S, Pertz HH, Kramer K, Seifert R, Schunack W, Elz S. Nα-Imidazolylalkyl and Pyridylalkyl Derivatives of Histaprodifen: Synthesis and in Vitro Evaluation of Highly Potent Histamine H1-Receptor Agonists Journal of Medicinal Chemistry. 46: 5458-5470. PMID 14640554 DOI: 10.1021/Jm0309147  0.326
2003 Gille A, Seifert R. MANT-substituted guanine nucleotides: a novel class of potent adenylyl cyclase inhibitors. Life Sciences. 74: 271-9. PMID 14607255 DOI: 10.1016/J.Lfs.2003.09.014  0.727
2003 Wenzel-Seifert K, Seifert R. Properties of Arg389-β 1 -Adrenoceptor-G sα Fusion Proteins: Comparison with Gly389-β 1 -Adrenoceptor-G sα Fusion Proteins Receptors & Channels. 9: 315-323. PMID 14527875 DOI: 10.3109/713745179  0.342
2003 Seifert R, Wenzel-Seifert K. The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors. Life Sciences. 73: 2263-80. PMID 12941430 DOI: 10.1016/S0024-3205(03)00654-4  0.416
2003 Gille A, Seifert R. Low-affinity interactions of BODIPY-FL-GTPgammaS and BODIPY-FL-GppNHp with G(i)- and G(s)-proteins. Naunyn-Schmiedeberg's Archives of Pharmacology. 368: 210-5. PMID 12920505 DOI: 10.1007/S00210-003-0783-7  0.692
2003 Gille A, Seifert R. Co-expression of the beta2-adrenoceptor and dopamine D1-receptor with Gsalpha proteins in Sf9 insect cells: limitations in comparison with fusion proteins. Biochimica Et Biophysica Acta. 1613: 101-14. PMID 12832091 DOI: 10.1016/S0005-2736(03)00174-3  0.679
2003 Wenzel-Seifert K, Seifert R. Functional differences between human formyl peptide receptor isoforms 26, 98, and G6. Naunyn-Schmiedeberg's Archives of Pharmacology. 367: 509-15. PMID 12679864 DOI: 10.1007/S00210-003-0714-7  0.397
2003 Gille A, Seifert R. 2'(3')-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors. The Journal of Biological Chemistry. 278: 12672-9. PMID 12566433 DOI: 10.1074/Jbc.M211292200  0.697
2003 Wenzel-Seifert K, Seifert R. Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor. Biochemical and Biophysical Research Communications. 301: 693-8. PMID 12565836 DOI: 10.1016/S0006-291X(03)00023-8  0.418
2003 Gille A, Wenzel-Seifert K, Doughty MB, Seifert R. GDP affinity and order state of the catalytic site are critical for function of xanthine nucleotide-selective Galphas proteins. The Journal of Biological Chemistry. 278: 7822-8. PMID 12499374 DOI: 10.1074/Jbc.M210162200  0.702
2002 Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 366: 381-416. PMID 12382069 DOI: 10.1007/S00210-002-0588-0  0.395
2002 Liu HY, Seifert R. Distinct interactions of G(salpha-long), G(salpha-short), and G(alphaolf) with GTP, ITP, and XTP. Biochemical Pharmacology. 64: 583-93. PMID 12167477 DOI: 10.1016/S0006-2952(02)01251-0  0.386
2002 Gille A, Liu HY, Sprang SR, Seifert R. Distinct interactions of GTP, UTP, and CTP with G(s) proteins. The Journal of Biological Chemistry. 277: 34434-42. PMID 12080068 DOI: 10.1074/Jbc.M204259200  0.698
2002 Houston C, Wenzel-Seifert K, Bürckstümmer T, Seifert R. The human histamine H2-receptor couples more efficiently to Sf9 insect cell Gs-proteins than to insect cell Gq-proteins: limitations of Sf9 cells for the analysis of receptor/Gq-protein coupling. Journal of Neurochemistry. 80: 678-96. PMID 11841575 DOI: 10.1046/J.0022-3042.2001.00746.X  0.394
2001 Kelley MT, Bürckstümmer T, Wenzel-Seifert K, Dove S, Buschauer A, Seifert R. Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists. Molecular Pharmacology. 60: 1210-25. PMID 11723228 DOI: 10.1124/Mol.60.6.1210  0.4
2001 Seifert R, Wenzel-Seifert K. Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis. The Journal of Biological Chemistry. 276: 42043-9. PMID 11559706 DOI: 10.1074/Jbc.M106621200  0.371
2001 Liu H, Wenzel-Seifert K, Seifert R. The olfactory G protein Gαolf possesses a lower GDP‐affinity and deactivates more rapidly than Gsαshort: consequences for receptor‐coupling and adenylyl cyclase activation Journal of Neurochemistry. 78: 325-338. PMID 11461968 DOI: 10.1046/J.1471-4159.2001.00422.X  0.465
2000 Wenzel-Seifert K, Seifert R. Molecular Analysis of β2-Adrenoceptor Coupling to Gs-, Gi-, and Gq-Proteins Molecular Pharmacology. 58: 954-966. PMID 11040042 DOI: 10.1124/Mol.58.5.954  0.349
1999 Wenzel-Seifert K, Arthur JM, Liu HY, Seifert R. Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3). The Journal of Biological Chemistry. 274: 33259-66. PMID 10559200 DOI: 10.1074/Jbc.274.47.33259  0.376
1999 Lee TW, Seifert R, Guan X, Kobilka BK. Restricting the mobility of Gs alpha: impact on receptor and effector coupling. Biochemistry. 38: 13801-9. PMID 10529225 DOI: 10.1021/Bi9908282  0.362
1999 Seifert R, Wenzel-Seifert K, Kobilka BK. GPCR-Galpha fusion proteins: molecular analysis of receptor-G-protein coupling. Trends in Pharmacological Sciences. 20: 383-9. PMID 10462762 DOI: 10.1016/S0165-6147(99)01368-1  0.353
1999 Klinker JF, Seifert R. Interaction of the retinal G-protein transducin with uracil nucleotides. Biochemical and Biophysical Research Communications. 262: 341-5. PMID 10462476 DOI: 10.1006/Bbrc.1999.1203  0.404
1999 Seifert R, Gether U, Wenzel-Seifert K, Kobilka BK. Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations. Molecular Pharmacology. 56: 348-58. PMID 10419554 DOI: 10.1124/Mol.56.2.348  0.303
1999 Klinker JF, Seifert R. Nucleoside diphosphate kinase activity in soluble transducin preparations biochemical properties and possible role of transducin-beta as phosphorylated enzyme intermediate. European Journal of Biochemistry. 261: 72-80. PMID 10103035 DOI: 10.1046/J.1432-1327.1999.00209.X  0.38
1999 Seifert R, Wenzel-Seifert K, Gether U, Lam VT, Kobilka BK. Examining the efficiency of receptor/G-protein coupling with a cleavable beta2-adrenoceptor-gsalpha fusion protein. European Journal of Biochemistry / Febs. 260: 661-6. PMID 10102993 DOI: 10.1046/J.1432-1327.1999.00161.X  0.346
1998 Wenzel-Seifert K, Lee TW, Seifert R, Kobilka BK. Restricting mobility of Gsalpha relative to the beta2-adrenoceptor enhances adenylate cyclase activity by reducing Gsalpha GTPase activity. The Biochemical Journal. 334: 519-24. PMID 9729456 DOI: 10.1042/Bj3340519  0.341
1998 Seifert R, Wenzel-Seifert K, Lee TW, Gether U, Sanders-Bush E, Kobilka BK. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. The Journal of Biological Chemistry. 273: 5109-16. PMID 9478963 DOI: 10.1074/Jbc.273.9.5109  0.317
1997 Klinker JF, Seifert R. Functionally nonequivalent interactions of guanosine 5'-triphosphate, inosine 5'-triphosphate, and xanthosine 5'-triphosphate with the retinal G-protein, transducin, and with Gi-proteins in HL-60 leukemia cell membranes. Biochemical Pharmacology. 54: 551-62. PMID 9337071 DOI: 10.1016/S0006-2952(97)00205-0  0.429
1997 Wenzel‐Seifert K, Lentzen H, Aktories K, Seifert R. Complex regulation of human neutrophil activation by actin filaments: dihydrocytochalasin B and botulinum C2 toxin uncover the existence of multiple cation entry pathways. Journal of Leukocyte Biology. 61: 703-711. PMID 9201261 DOI: 10.1002/Jlb.61.6.703  0.351
1997 Klinker JF, Seifert R. Morphine and muscle relaxants are receptor-independent G-protein activators and cromolyn is an inhibitor of stimulated G-protein activity. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 46: 46-50. PMID 9085143 DOI: 10.1007/S000110050058  0.372
1996 Wenzel-Seifert K, Krautwurst D, Lentzen H, Seifert R. Concanavalin A and mistletoe lectin I differentially activate cation entry and exocytosis in human neutrophils: lectins may activate multiple subtypes of cation channels. Journal of Leukocyte Biology. 60: 345-355. PMID 8830791 DOI: 10.1002/Jlb.60.3.345  0.329
1996 Klinker JF, Wenzel-Seifert K, Seifert R. G-protein-coupled receptors in HL-60 human leukemia cells. General Pharmacology-the Vascular System. 27: 33-54. PMID 8742493 DOI: 10.1016/0306-3623(95)00107-7  0.422
1996 Burde R, Seifert R. Stimulation of histamine H2- (and H1)-receptors activates Ca2+ influx in all-atrans-retinoic acid-differentiated HL-60 cells independently of phospholipase C or adenylyl cyclase Naunyn-Schmiedebergs Archives of Pharmacology. 353: 123-129. PMID 8717151 DOI: 10.1007/Bf00168748  0.358
1996 Wenzel-Seifert K, Krautwurst D, Musgrave I, Seifert R. Thapsigargin activates univalent- and bivalent-cation entry in human neutrophils by a SK&F I3 96365- and Gd3+-sensitive pathway and is a partial secretagogue: involvement of pertussis-toxin-sensitive G-proteins and protein phosphatases 1/2A and 2B in the signal-transduction pathway. Biochemical Journal. 314: 679-686. PMID 8670085 DOI: 10.1042/Bj3140679  0.368
1996 Burde R, Dippel E, Seifert R. Receptor-independent G protein activation may account for the stimulatory effects of first-generation H1-receptor antagonists in HL-60 cells, basophils, and mast cells Biochemical Pharmacology. 51: 125-131. PMID 8615880 DOI: 10.1016/0006-2952(95)02123-X  0.414
1996 Klinker JF, Laugwitz K, Hagelüken A, Seifert R. Activation of GTP formation and high-affinity GTP hydrolysis by mastoparan in various cell membranes: G-protein activation via nucleoside diphosphate kinase, a possible general mechanism of mastoparan action Biochemical Pharmacology. 51: 217-223. PMID 8573186 DOI: 10.1016/0006-2952(95)02119-1  0.417
1996 Detert H, Leschke C, Tögel W, Seifert R, Schunacki W. 2-Alkyl-substituted histamines and hydroxyethylimidazoles with G-protein-stimulatory activity European Journal of Medicinal Chemistry. 31: 397-405. DOI: 10.1016/0223-5234(96)89166-5  0.439
1995 Klinker JF, Hageluken A, Griinbaum L, Seifert R. Direct and indirect receptor-independent G-protein activation by cationic-amphiphilic substances. Studies with mast cells, HL-60 human leukemic cells and purified G-proteins. Experimental Dermatology. 4: 231-239. PMID 8528595 DOI: 10.1111/J.1600-0625.1995.Tb00251.X  0.428
1995 Hagelüken A, Grünbaum L, Klinker JF, Nürnberg B, Harhammer R, Schultz G, Leschke C, Schunack W, Seifert R. Histamine receptor-dependent and/or -independent activation of guanine nucleotide-binding proteins by histamine and 2-substituted histamine derivatives in human leukemia (HL-60) and human erythroleukemia (HEL) cells Biochemical Pharmacology. 49: 901-914. PMID 7741762 DOI: 10.1016/0006-2952(94)00514-M  0.446
1995 Klinker JF, Seifert R. Synthetic lipopeptides activate nucleoside diphosphate kinase in HL-60 membranes. Biochemical and Biophysical Research Communications. 209: 575-81. PMID 7733927 DOI: 10.1006/Bbrc.1995.1539  0.335
1995 Hagelüken A, Burde R, Nürnberg B, Harhammer R, Buschauer A, Seifert R. Cationic-amphiphilic arpromidine-derived guanidines and a histamine trifluoromethyl-toluidide derivative may activate pertussis toxin-sensitive G-proteins by a receptor-independent mechanism. Naunyn-Schmiedebergs Archives of Pharmacology. 351: 305-308. PMID 7609785 DOI: 10.1007/Bf00233251  0.447
1995 Schwaner I, Offermanns S, Spicher K, Seifert R, Schultz G. Differential activation of Gi and Gs proteins by E- and I-type prostaglandins in membranes from the human erythroleukaemia cell line, HEL. Biochimica Et Biophysica Acta. 1265: 8-14. PMID 7532011 DOI: 10.1016/0167-4889(94)00198-N  0.423
1995 Musgrave IF, Seifert R. α2A-adrenoceptors mediate activation of non-selective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells: No evidence for a functional role of imidazoline receptors in modulating calcium Biochemical Pharmacology. 49: 187-196. PMID 7530955 DOI: 10.1016/S0006-2952(94)00432-3  0.402
1995 Detert H, Hagelüken A, Seifert R, Schunack W. 2-Substituted histamines with G-protein-stimulatory activity European Journal of Medicinal Chemistry. 30: 271-276. DOI: 10.1016/0223-5234(96)88235-3  0.438
1994 Wenzel-Seifert K, Schächtele C, Seifert R. N-Protein Kinase C Isoenzymes May Be Involved in the Regulation of Various Neutrophil Functions Biochemical and Biophysical Research Communications. 200: 1536-1543. PMID 8185608 DOI: 10.1006/Bbrc.1994.1625  0.369
1994 Naim M, Seifert R, Nürnberg B, Grünbaum L, Schultz G. Some taste substances are direct activators of G-proteins Biochemical Journal. 297: 451-454. PMID 8110180 DOI: 10.1042/Bj2970451  0.359
1994 Wenzel-Seifert K, Schächtele C, Hummel R, Grünbaum L, Seifert R. Evidence That Inhibition Of Phorbol Ester- Induced Superoxide Anion Formation By Cyclosporin A In Phagocytes Is Not Mediated By Direct Inhibition Of Protein Kinase C Biochemical Pharmacology. 48: 859-864. PMID 8093097 DOI: 10.1016/0006-2952(94)90355-7  0.371
1994 Seifert R, Grünbaum L, Schultz G. Histamine H1-receptors in HL-60 monocytes are coupled to Gi-proteins and pertussis toxin-insensitive G-proteins and mediate activation of Ca2+ influx without concomitant Ca2+ mobilization from intracellular stores Naunyn-Schmiedebergs Archives of Pharmacology. 349: 355-361. PMID 8058107 DOI: 10.1007/Bf00170880  0.352
1994 Berg M, Offermanns S, Seifert R, Schultz G. Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets. The American Journal of Physiology. 266: C1684-91. PMID 8023898 DOI: 10.1152/Ajpcell.1994.266.6.C1684  0.329
1994 Klinker JF, Hagelüken A, Grünbaum L, Heilmann I, Nürnberg B, Harhammer R, Offermanns S, Schwaner I, Ervens J, Wenzel-Seifert K, Müller T, Seifert R. Mastoparan may activate GTP hydrolysis by Gi-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase. Biochemical Journal. 304: 377-383. PMID 7998971 DOI: 10.1042/Bj3040377  0.454
1994 Klinker JF, Schwaner I, Offermanns S, Hagelüken A, Seifert R. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants Biochemical Pharmacology. 48: 1857-1864. PMID 7986196 DOI: 10.1016/0006-2952(94)90583-5  0.341
1994 Hagelüken A, Grünbaum L, Nürnberg B, Harhammer R, ScHunack W, Seifert R. Lipophilic β-adrenoceptor antagonists and local anesthetics are effective direct activators of g-proteins Biochemical Pharmacology. 47: 1789-1795. PMID 7911302 DOI: 10.1016/0006-2952(94)90307-7  0.436
1994 Musgrave IF, Seifert R. Human neutrophils and HL-60 cells do not possess α2-adrenoceptors Biochemical Pharmacology. 47: 233-239. PMID 7905732 DOI: 10.1016/0006-2952(94)90011-6  0.312
1994 Detert H, Hagelüken A, Leschke C, Nümberg B, Seifert R, Schunack W. P88 receptor-independent G-protein activation by 2-substiituted histamines European Journal of Pharmaceutical Sciences. 2: 140. DOI: 10.1016/0928-0987(94)90261-5  0.355
1994 Nümberg B, Harteneck C, Leopoldt D, Harhammer R, Seifert R, Hagelüken A, Detert H, Schunack W, Hoppe R, Nümberg E. FC19 activation of G-proteins in physiological and reconstituted membranous systems European Journal of Pharmaceutical Sciences. 2: 105. DOI: 10.1016/0928-0987(94)90128-7  0.349
1994 Klinker J, Hagelüken A, Nürnberg B, Seifert R. SC12 G-protein activation via nucleoside diphosphate kinase European Journal of Pharmaceutical Sciences. 2: 93. DOI: 10.1016/0928-0987(94)90094-9  0.346
1993 Musgrave IF, Genieser HG, Maronde E, Seifert R. Preparations of Rp-cyclic adenosine 3',5'-phosphorothioate (Rp-cAMPS) can contain biologically active amounts of adenosine. Febs Letters. 318: 227-230. PMID 8382631 DOI: 10.1016/0014-5793(93)80517-X  0.394
1993 Klinker JF, Höer A, Schwaner I, Offermanns S, Wenzel-Seifert K, Seifert R. Lipopeptides activate Gi-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Biochemical Journal. 296: 245-251. PMID 8250850 DOI: 10.1042/Bj2960245  0.437
1993 Wenzel-Seifert K, Seifert R. Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations. Naunyn-Schmiedeberg's Archives of Pharmacology. 348: 7-13. PMID 7690907 DOI: 10.1007/Bf00168530  0.426
1992 Wenzel-Seifert K, Ervens J, Seifert R. Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils. Naunyn-Schmiedeberg's Archives of Pharmacology. 344: 396-402. PMID 1722562 DOI: 10.1007/Bf00172578  0.306
1992 Klinz F, Seifert R, Schwaner I, Gausepohl H, Frank R, Schultz G. Generation of specific antibodies against the rap1A, rap1B and rap2 small GTP-binding proteins. Analysis of rap and ras proteins in membranes from mammalian cells. Febs Journal. 207: 207-213. PMID 1628649 DOI: 10.1111/J.1432-1033.1992.Tb17039.X  0.351
1992 Ervens J, Seifert R. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a no-independent mechanism. Biochemical Pharmacology. 44: 637-644. PMID 1324680 DOI: 10.1016/0006-2952(92)90397-2  0.372
1992 Offermanns S, Seifert R, Metzger JW, Jung G, Lieberknecht A, Schmidt U, Schultz G. Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells. Biochemical Journal. 282: 551-557. PMID 1312332 DOI: 10.1042/Bj2820551  0.322
1992 Seifert R, Serke S, Huhn D, Bessler WG, Hauschildt S, Metzger J, Wiesmüller K, Jung G. Incomplete functional differentiation of HL‐60 leukemic cells by synthetic lipopetides Febs Journal. 203: 143-151. PMID 1309696 DOI: 10.1111/J.1432-1033.1992.Tb19839.X  0.395
1992 Krautwurst D, Seifert R, Hescheler J, Schultz G. Formyl peptides and ATP stimulate Ca2+ and Na+ inward currents through non-selective cation channels via G-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Involvement of Ca2+ and Na+ in the activation of beta-glucuronidase release and superoxide production. Biochemical Journal. 288: 1025-1035. PMID 1281979 DOI: 10.1042/Bj2881025  0.315
1991 Seifert R, Hilgenstock G, Fassbender M, Distler A. Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertension. Journal of Hypertension. 9: 147-153. PMID 1849530 DOI: 10.1097/00004872-199102000-00008  0.343
1991 Ervens J, Seifert R. Differential modulation by N4, 2'-O-dibutyryl cytidine 3':5'-cyclic monophosphate of neutrophil activation. Biochemical and Biophysical Research Communications. 174: 258-267. PMID 1703410 DOI: 10.1016/0006-291X(91)90514-8  0.316
1991 Ervens J, Schultz G, Seifert R. Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2,2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate. Naunyn-Schmiedebergs Archives of Pharmacology. 343: 370-376. PMID 1649410 DOI: 10.1007/Bf00179041  0.319
1991 Ervens J, Schultz G, Seifert R. Differential regulation of chemoattractant-induced superoxide formation in human neutrophils by cell-permeant analogues of cyclic AMP and cyclic GMP. Biochemical Society Transactions. 19: 59-63. PMID 1645316 DOI: 10.1042/Bst0190059  0.313
1990 Seifert R, Schultz G, Richter-Freund M, Metzger J, Wiesmüller KH, Jung G, Bessler WG, Hauschildt S. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides. Biochemical Journal. 267: 795-802. PMID 2160237 DOI: 10.1042/Bj2670795  0.379
1990 Wenzel-Seifert K, Seifert R. Nucleotide-, Chemotactic Peptide- and Phorbol Ester-Induced Exocytosis in HL-60 Leukemic Cells Immunobiology. 181: 298-316. PMID 1966023 DOI: 10.1016/S0171-2985(11)80499-7  0.395
1990 Burde R, Buschauer A, Seifert R. Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine. Are cell type-specific H2-receptors involved in the regulation of NADPH oxidase? Naunyn-Schmiedeberg's Archives of Pharmacology. 341: 455-61. PMID 1694972 DOI: 10.1007/Bf00176340  0.359
1989 Seifert R, Schultz G. Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends in Pharmacological Sciences. 10: 365-369. PMID 2690427 DOI: 10.1016/0165-6147(89)90009-6  0.402
1989 Burde R, Seifert R, Buschauer A, Schultz G. Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors. Naunyn-Schmiedebergs Archives of Pharmacology. 340: 671-678. PMID 2559336 DOI: 10.1007/Bf00717743  0.392
1989 Seifert R, Burde R, Schultz G. Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells. Naunyn-Schmiedebergs Archives of Pharmacology. 340: 101-106. PMID 2552328 DOI: 10.1007/Bf00169214  0.306
1989 Seifert R, Burde R, Schultz G. Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides Biochemical Journal. 259: 813-819. PMID 2543370 DOI: 10.1042/Bj2590813  0.412
1989 Seifert R, Wenzel K, Eckstein F, Schultz G. Purine and pyrimidine nucleotides potentiate activation of NADPH oxidase and degranulation by chemotactic peptides and induce aggregation of human neutrophils via G proteins. European Journal of Biochemistry. 181: 277-85. PMID 2540969 DOI: 10.1111/J.1432-1033.1989.Tb14722.X  0.357
1989 Rudolph U, Koesling D, Hinsch KD, Seifert R, Bigalke M, Schultz G, Rosenthal W. G-protein alpha-subunits in cytosolic and membranous fractions of human neutrophils. Molecular and Cellular Endocrinology. 63: 143-53. PMID 2502457 DOI: 10.1016/0303-7207(89)90090-7  0.361
1989 Seifert R, Jungblut P, Schultz G. Differential expression of cytosolic activation factors for NADPH oxidase in HL-60 leukemic cells Biochemical and Biophysical Research Communications. 161: 1109-1117. PMID 2472788 DOI: 10.1016/0006-291X(89)91357-0  0.347
1988 Seifert R, Schächtele C, Rosenthal W, Schultz G. Activation of protein kinase C by cis- and trans-fatty acids and its potentiation by diacylglycerol Biochemical and Biophysical Research Communications. 154: 20-26. PMID 3395325 DOI: 10.1016/0006-291X(88)90643-2  0.303
1988 Norgauer J, Kownatzki E, Seifert R, Aktories K. Botulinum C2 toxin ADP-ribosylates actin and enhances O2- production and secretion but inhibits migration of activated human neutrophils. Journal of Clinical Investigation. 82: 1376-1382. PMID 2844854 DOI: 10.1172/Jci113741  0.342
1988 Seifert R, Rosenthal W, Schultz G, Wieland T, Gierschick P, Jakobs KH. The role of nucleoside-diphosphate kinase reactions in G protein activation of NADPH oxidase by guanine and adenine nucleotides Febs Journal. 175: 51-55. PMID 2841126 DOI: 10.1111/J.1432-1033.1988.Tb14165.X  0.374
1988 Seifert R, Schächtele C. Studies with protein kinase C inhibitors presently available cannot elucidate the role of protein kinase C in the activation of NADPH oxidase Biochemical and Biophysical Research Communications. 152: 585-592. PMID 2835037 DOI: 10.1016/S0006-291X(88)80078-0  0.382
1988 Schächtele C, Seifert R, Osswald H. Stimulus-dependent inhibition of platelet aggregation by the protein kinase C inhibitors polymyxin B, H-7 and staurosporine. Biochemical and Biophysical Research Communications. 151: 542-547. PMID 2831891 DOI: 10.1016/0006-291X(88)90628-6  0.341
1987 Seifert R, Schultz G. Fatty‐acid‐induced activation of NADPH oxidase in plasma membranes of human neutrophils depends on neutrophil cytosol and is potentiated by stable guanine nucleotides Febs Journal. 162: 563-569. PMID 3549290 DOI: 10.1111/J.1432-1033.1987.Tb10676.X  0.374
1987 Seifert R, Schultz G. Reversible activation of NADPH oxidase in membranes of HL-60 human leukemic cells Biochemical and Biophysical Research Communications. 146: 1296-1302. PMID 3113431 DOI: 10.1016/0006-291X(87)90790-X  0.368
1986 Seifert R, Rosenthal W, Schultz G. Guanine nucleotides stimulate NADPH oxidase in membranes of human neutrophils Febs Letters. 205: 161-165. PMID 3017756 DOI: 10.1016/0014-5793(86)80886-9  0.389
Show low-probability matches.